Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the National Institute for Health and Care Excellence (a) review and (b) update clinical guidelines on (i) diagnosis and (ii) treatment of type 1 diabetes and eating disorders.
The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for determining whether its guidelines should be reviewed or updated in light of new evidence. NICE takes a proactive approach to surveillance, monitoring for changes in the evidence base that may impact on its recommendations. Topics for new or updated guidance are considered through the NICE prioritisation process. Decisions as to whether NICE will create new, or update existing, guidance are overseen by a prioritisation board, chaired by NICE’s Chief Medical Officer.
NICE intends to carry out focussed updates to all diabetes guidance to take account of changes in insulin availability, but has no current plans for further updates to its guidelines on type 1 diabetes or eating disorders.